Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RACING trial: statin monotherapy vs statin + ezetimibe in high-risk cardiovascular disease
KCT0002910Phase 4Completed
- Sponsor
- Hanmi Pharmaceutical
- Start
- Feb 2017
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of ulinastatin, ezetimibe in atherosclerotic disease, myocardial infarction (MI), unstable angina, stable angina, ischemic stroke, sponsored by Hanmi Pharmaceutical. Started Feb 2017; status: completed.
02
Drugs
ulinastatinezetimibe
03
Conditions
atherosclerotic diseasemyocardial infarction (MI)unstable anginastable anginaischemic stroke
Beyond the preview
Go deeper on KCT0002910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0002910.